2-chlorodeoxyadenosine , a new lymphocyte-selective , anti-neoplastic drug was administered to 18 patients with advanced chronic lymphocytic leukemia of b-cell origin .
C0092801
2-chlorodeoxyadenosine
C0023434
chronic lymphocytic leukemia